Yao-Hsu Yang
Chang Gung University
424 Papers
1.6K Citations
Yao-Hsu Yang is an academic researcher from Chang Gung University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 40, co-authored 390 publications. Previous affiliations of Yao-Hsu Yang include Chongqing Medical University & University of California, Los Angeles.
Chat about Author
Papers
Risk of schizophrenia among people with obsessive-compulsive disorder: A nationwide population-based cohort study.
TL;DR: In conclusion, OCD diagnosis, male gender, age of OCD onset before 20 years, comorbidity of autistic disorder, and antipsychotic use were associated with higher risk of schizophrenia.
Increased transforming growth factor-beta (TGF-β)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch–Schönlein purpura
TL;DR: Although more studies are needed, the high prevalence of IgA aCL and increased TGF‐β‐secreting T cells in children with acute HSP revealed some points which should permit a better understanding of the pathogenesis of HSP.
Linoleic acid metabolite levels and transepidermal water loss in children with atopic dermatitis.
TL;DR: Deficits in n-6 EFAs were correlated with the severity of AD by affecting skin barrier function and cutaneous inflammation and the link between impaired n- 6 EFA metabolism and IgE level could not be defined.
Chronic Hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients.
Won Choi,Terry Cheuk-Fung Yip,W. R. Kim,Leland J. Yee,Craig Brooks-Rooney,T. Curteis,Laura J Clark,Zarena Jafry,Chien-Hung Chen,Chi-Yi Chen,Yi-Hsiang Huang,Young-Joo Jin,Dae Won Jun,Jin Wook Kim,Neung Hwa Park,Cheng-Yuan Peng,Hyun Phil Shin,Jung Woo Shin,Yao-Hsu Yang,Grace Lai-Hung Wong,Young-Suk Lim +20 more
TL;DR: In a multinational cohort of adult patients with HBeAg-positive without cirrhosis and with chronic hepatitis B, baseline HBV viral load was significantly associated with HCC risk despite antiviral treatment.
Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
TL;DR: Exposure to PPIs during first line gefitinib treatment significantly decreased overall survival of patients with NSCLC, and concurrent use of PPIs was associated with lower overall survival.